The STOP-ACEi Trial - Apt timing for this long awaited randomised controlled trial - Validation of the syndrome of late-onset renal failure from angiotensin blockade (LORFFAB)?-Reference-Cited by-同舟云学术

The STOP-ACEi Trial - Apt timing for this long awaited randomised controlled trial - Validation of the syndrome of late-onset renal failure from angiotensin blockade (LORFFAB)?

Published:2016-12-09 Issue:1 Volume:71 Page:e12916
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Onuigbo Macaulay Amechi Chukwukadibia¹²

Affiliation:

1. Mayo Clinic College of Medicine; Rochester MN USA

2. Department of Nephrology; Mayo Clinic Health System; Eau Claire WI USA

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijcp.12916/fullpdf

Reference22 articles.

1. Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease;Bhandari;Nephrol Dial Transplant,2016

2. Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience;Onuigbo;Med Sci Monit,2005

3. Late-onset renal failure from RAAS blockade;Onuigbo;Kidney Int,2006

4. Late onset azotemia from RAAS blockade in CKD patients with normal renal arteries and no precipitating risk factors;Onuigbo;Ren Fail,2008

5. Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients;Onuigbo;Int Urol Nephrol,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Four-Year Report on Renal Outcomes Following the Elective Withdrawal of Long-Term Renin-Angiotensin-Aldosterone Blockade in a Cohort of Patients With Otherwise Inexplicable New-Onset and Progressive Acute Kidney Injury;Cureus;2022-10-28

2. Four-Year Report on Renal Outcomes Following Elective Withdrawal of Long-Term RAAS Blockade in a Cohort of Patients with Otherwise Inexplicable New-Onset and Progressive Acute Kidney Injury;2022-08-05

3. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?;Nephron;2019

4. Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?;Journal of the American Heart Association;2018-06-05

5. Late onset renal failure from angiotensin blockade (LORFFAB) and the syndrome of rapid onset endstage renal disease (SORO-ESRD) revisited – Two case reports from Mayo Clinic Health System, Northwestern Wisconsin, USA; a review paper;Journal of Renal Injury Prevention;2018-01-02